H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Shire Human Genetic Therapies Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Shire Human Genetic Therapies Inc.
MARank #FEIN 04-3027191

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPShire Human Genetic Therapies Inc.
Total filings80,813292
Certified %98.23%81.16%
Denied %1.09%2.05%
Withdrawn %0.61%4.45%
Cert-withdrawn %0.07%12.33%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePAMA

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Shire Human Genetic Therapies Inc.

DOL case-status mix.

Outcome breakdown: Certified 81.2%, Cert-withdrawn 12.3%, Withdrawn 4.5%, Denied 2.1%
Outcome breakdown
OutcomeShare
Certified81.2%
Cert-withdrawn12.3%
Withdrawn4.5%
Denied2.1%
Certified81.2%
Cert-withdrawn12.3%
Withdrawn4.5%
Denied2.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Shire Human Genetic Therapies Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201015
FY201115
FY201219
FY201313
FY201428
FY201512
FY201619
FY201728
FY201842
FY201931
FY202015
FY202113
FY20222
FY20235
FY202421
FY20258
FY20266

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Shire Human Genetic Therapies Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.